Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 12, 2019

SELL
$22.03 - $32.01 $1.93 Million - $2.81 Million
-87,660 Closed
0 $0
Q3 2018

Nov 15, 2018

SELL
$30.0 - $40.85 $3.4 Million - $4.63 Million
-113,420 Reduced 56.41%
87,660 $2.77 Million
Q2 2018

Aug 15, 2018

BUY
$26.4 - $42.0 $3.74 Million - $5.94 Million
141,505 Added 237.52%
201,080 $7.81 Million
Q1 2018

May 15, 2018

BUY
$18.43 - $28.8 $1.1 Million - $1.72 Million
59,575 New
59,575 $1.64 Million

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $227M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Castleark Management LLC Portfolio

Follow Castleark Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.